Qamar Khan, DO
Pain Medicine · South Jordan, UTNPI 1407026420
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Medtronic at 34.4% of the total. That places this record below the midpoint for pain medicine clinicians in UT, where the typical reported total is $3,451.
Across 115 payments — averaging $13.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$533
- Pfizer$203
- AbbVie$173
- Boston Scientific$90
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$87
- Vertex$46
- plus $417 from 19 others
What the payments were for
- Food & beverage$1,549100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 55 | $533 |
| Pfizer | 12 | $203 |
| AbbVie(2 entities) | 10 | $173 |
| Boston Scientific | 5 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| Vertex | 2 | $46 |
| Nevro Corp. | 2 | $45 |
| Almatica Pharma LLC | 2 | $40 |
| Bioventus LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| GRT US Holding, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 2 | $26 |
| Si-bone, Inc. | 1 | $22 |
| Abbott | 1 | $22 |
| SPR Therapeutics, Inc | 1 | $18 |
| Amgen | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| AstraZeneca | 1 | $11 |
| Stratus Medical, LLC | 1 | $8 |
How this compares
$1,549 in reported general payments places this provider in the 35th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $474 |
| Gabapentin | 12 | $336 |
| Diclofenac Sodium | 16 | $298 |
| Baclofen | 21 | $198 |
| Tizanidine Hcl | 17 | $119 |
| Cephalexin | 17 | $113 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in South Jordan
- Ryan MurphySouth Jordan$2K
- Maria SchwartzSalt Lake City$813K
- Jeremy JoyalDraper$170K
- Lynn WebsterSalt Lake City$160K
- Benjamin HumpherysLayton$120K
- Derek HaightDraper$78K
- Jon ObraySt George$24K
- Jason BeckstrandWest Jordan$17K
- Austin AlbrightSalt Lake City$14K
- Jeffrey PenceWest Valley City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.